查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1809746

全球血液製品市場（按產品、成分、加工自動化、製備方法、應用和最終用戶）預測（2025-2030 年）

Blood Preparation Market by Offerings, Component, Processing Automation, Preparation Method, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球血液製品市場規模預計2024年將達到455.4億美元，2025年將達480.9億美元，2030年將達到636.6億美元，複合年成長率為5.74%。

主要市場統計數據
基準年：2024年 455.4億美元
預計年份：2025年 480.9億美元
預測年份：2030年 636.6億美元
複合年成長率（%） 5.74%

全面了解當前血液製品生態系統，重點關注影響營運策略的技術推動因素、相關人員的優先事項和採購考慮因素

隨著醫療機構尋求更安全、更有效率、更可追溯的生物製藥流程，血液製品生態系統正經歷技術和營運的快速改進。血液採集和儲存硬體的進步，加上用於機構管理和溫度監控的軟體層的不斷擴展，正在重新定義捐血、處理、儲存和分配的工作流程。從血庫和醫院輸血服務到門診手術中心和研究機構，相關人員正在重新調整採購重點，以強調彈性、自動化和整合品管。

對技術、營運和採購轉型變化的綜合看法，這些變化正在重新定義血液製品的安全性、自動化和供應商參與度

血液製品產業格局正沿著幾個相互融合的趨勢發生變化，這些趨勢正在改變供應鏈和臨床實踐。首先，自動化正在超越單一儀器的優勢，轉向整合自動化成分提取、離心和溫度感知儲存系統的協同工作流程，從而減少人工勞動和差異性。其次，白血球減少、輻照和病原體惰性等安全技術正在更早納入加工流程中，以降低下游風險並支援更廣泛的臨床使用案例。第三，軟體驅動的流程管治日趨成熟，溫度監控和血液機構系統提供了先前依賴人工記錄的審核和合規性支援。

清楚分析累積關稅如何重塑整個血液製品價值鏈的採購動態、供應商策略和營運彈性

近期的關稅措施為整個血液製品價值鏈的採購和供應彈性帶來了複雜性。進口零件、資本設備和某些耗材的累積關稅增加了依賴跨境供應商的醫療保健機構的總體擁有成本，促使許多機構重新評估供應商集中度和前置作業時間。因此，採購團隊正在優先考慮雙源策略，並加強與區域製造商的合作，以減輕貿易政策波動的影響。

關鍵細分洞察，將產品、加工方法、臨床用途、自動化程度、成分和最終用戶需求與採購和創新重點進行映射

細分推動產品開發藍圖和採購選擇，因為最終用戶需要清楚了解產品如何滿足他們的臨床和營運需求。這個市場由耗材、設備和軟體組成。耗材包括血液分離套件、血袋系統、白血球減少過濾器、轉移裝置、管路和針頭等，這些決定了血液中心和醫院每次手術的成本和利潤。設備包括採集設備、輻照設備、病原體減少系統、處理設備和儲存設施。採集設備進一步分為血液分離機和採血攪拌機。處理設備包括自動成分提取機和離心機。儲存設施包括血庫冰箱、超低溫冷凍庫、血漿冷凍庫、血小板培養箱和攪拌器。軟體涵蓋血液營業單位解決方案和溫度監控平台，可實現庫存管理和監管可追溯性。

細緻入微的區域綜合分析，闡明美洲、歐洲、中東和非洲地區以及亞太地區的動態將如何影響採用、供應彈性和監管合規性

區域動態對供應鏈、監管預期以及新血液製品技術的採用時間表有重大影響。美洲地區擁有龐大且完善的血液服務基礎設施、先進的醫院系統，日益重視自動化和安全技術。在這種環境下，採購決策受到報銷框架、既定的供應商關係以及溫度敏感產品遠距配送的現實影響。

提供可操作的企業級洞察，了解供應商策略、服務模式和夥伴關係方式如何塑造整個血液製品生態系統的競爭優勢

血液製品領域的競爭力更取決於生態系定位，而非單一產品優勢。領先的供應商透過整合拋棄式、固定設備和軟體功能的綜合產品組合實現差異化，從而實現端到端的價值提案，滿足採購偏好，減少供應商介面，並實現可預測的生命週期成本。領先供應商採取的策略行動包括：與臨床網路建立夥伴關係檢驗新的加工技術；投資區域服務點以縮短維護前置作業時間；以及提供培訓和認證計劃以減少採用先進設備的阻力。

為供應商、衛生系統和採購領導者提供實用且優先的建議，以增強血液製品的彈性、安全性和技術整合

產業領導者應優先考慮一系列策略行動，直接解決供應彈性、安全性和整合問題。首先，採用模組化採購策略，平衡血液採集和儲存設備的資本投資與耗材及維護的長期契約，以穩定總體擁有成本，並降低受關稅主導的價格籌資策略風險。其次，加快血液機構和溫度監測的軟體整合，以創建透明、審核的工作流程，減少人為錯誤並支援法規遵循。

一個強大的多方法研究框架，結合一級相關人員訪談、二級技術和監管整合以及三角主題檢驗，以支持策略洞察

本執行摘要的分析結合了多種方法的研究途徑，旨在產生可操作的、基於證據的見解。二次資訊整合利用了同行評審文獻、監管指南、技術標準和製造商技術規範，以全面整體情況技術、流程和合規性要求。初步研究透過與血庫主任、醫院輸血科主任、採購專業人員、臨床病理學家和設備工程師進行結構化訪談，以突顯現實世界中採用此技術的限制和促進因素。

策略重點與營運協調的關鍵整合，將安全性、彈性和完整性統一為血液製品相關人員的核心必要事項

這意味著醫療保健機構和供應商必須從交易互動轉向整合價值的夥伴關係關係，將彈性採購、自動化和數據驅動的品質系統結合在一起。醫療保健機構不應將流程自動化、病原體控制和軟體管治的投資僅視為資本計劃，而應將其視為實現臨床一致性和供應彈性的策略性槓桿。提供模組化、服務豐富且可互通解決方案的供應商最有能力滿足從門診手術中心到大型醫院網路等不同終端使用者的細微需求。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 照護現場血液製品設備的出現，方便了偏遠診所的現場輸血準備
  • 利用冷凍乾燥技術將常溫血液製品轉變為無低溫運輸儲存解決方案
  • 自動血液分離系統的整合可加速成分分離並降低污染風險
  • 增加對單一捐贈者血液分離平台的投資，以最佳化產量並最大限度地降低捐贈者暴露風險
  • 引入人工智慧捐贈者篩檢演算法，提高匹配準確性並減少輸血反應
  • 開發一種通用血型酶，可轉換 A 和 B 抗原，以緩解相容性問題
  • 加速採用血小板和血漿的病原體減少技術，以標準化安全性並延長保存期限
  • 先進的紅血球添加劑和復原解決方案可提高輸血後的活力並延長保存期限
  • 使用 RFID 和物聯網資料記錄器實現端到端數位可追溯性，以確保監管鍊和溫度合規性
  • 由於捐贈者的不確定性和區域性血液短缺迫使醫院尋求穩定的供應，合約血液處理和物流外包正在增加

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章血液製品市場類型

  • 耗材
    • 血液成分採集試劑套件
    • 血袋系統
    • 白血球去除過濾器
    • 轉移裝置
    • 管子和針頭
  • 裝置
    • 收集裝置
      • 血液採集機
      • 採血攪拌機
    • 照射裝置
    • 病原體減少系統
    • 加工設備
      • 自動元件擷取裝置
      • 離心機
    • 倉儲設備
      • 血庫冰箱
      • 低溫冷凍庫
      • 血漿冷凍庫
      • 血小板培養箱和攪拌器
  • 軟體
    • 血液營業單位
    • 溫度監測

第9章血液製品市場（依成分）

  • 電漿
  • 血小板
  • 紅血球
  • 全血

第10章血液製品市場（按加工自動化）

  • 全自動
  • 手動的
  • 半自動

第11章血液製品市場依製備方法

  • 單採血液成分處理
  • 提取工作流程
  • 冷凍儲存
  • 輻照
  • 白血球減少症
  • 病原體去活化
  • 清洗和調整音量
  • 全血處理

第12章血液製品市場應用

  • 血漿衍生療法
    • 自體免疫和神經系統疾病
    • 肝病及嚴重疾病治療
    • 原發性免疫力缺乏缺陷症
  • 研究與生物製造
  • 輸血支持
    • 貧血管理
    • 心血管和移植
    • 血液疾病
    • 婦產科
    • 腫瘤治療

第13章 血液製品市場（依最終用戶）

  • 門診手術中心
  • 血庫
  • 診所
  • 醫院

第 14 章：美洲血液製品市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

15. 歐洲、中東和非洲血液製品市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

第16章：亞太血液製品市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第17章競爭格局

  • 市佔率分析（2024年）
  • FPNV定位矩陣（2024年）
  • 競爭分析
    • Fresenius Kabi AG
    • Terumo Corporation
    • Grifols, SA
    • GVS SpA
    • Macopharma SAS
    • Baxter International Inc.
    • CSL Limited
    • B. Braun Melsungen AG
    • Ortho Clinical Diagnostics Inc.
    • Abbott Laboratories
    • AdvaCare Pharma
    • AstraZeneca PLC
    • Bayer AG
    • Becton, Dickinson, and Company
    • Cardinal Health
    • Daiichi Sankyo
    • Exelint International, Co.
    • GlaxoSmithKline PLC
    • Greiner Bio-One International GmbH
    • Medtronic PLC
    • Pfizer Inc.
    • QIAGEN NV
    • SARSTEDT AG & Co. KG
    • Shanghai Kohope Medical Devices Co., Ltd.
    • Immucor, Inc.
    • Octapharma AG
    • Kedrion Holding SpA
    • LFB SA
    • Sanquin
    • Medline Industries, Inc.
    • Mitra Industries Private Limited
    • Delcon SRL
    • Labtron Equipment Ltd
    • Nipro Corporation
    • Labotronics Scientific LTD.

第18章 研究人工智慧

第19章 研究統計

第20章 研究聯絡人

第21章 研究報導

第22章 附錄

Product Code: MRR-535C62918769

The Blood Preparation Market was valued at USD 45.54 billion in 2024 and is projected to grow to USD 48.09 billion in 2025, with a CAGR of 5.74%, reaching USD 63.66 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 45.54 billion
Estimated Year [2025] USD 48.09 billion
Forecast Year [2030] USD 63.66 billion
CAGR (%) 5.74%

A comprehensive orientation to the current blood preparation ecosystem highlighting technological enablers, stakeholder priorities, and procurement considerations shaping operational strategy

The blood preparation ecosystem is undergoing a period of rapid technological and operational refinement as institutions seek safer, more efficient, and more traceable flows of biological products. Advances in collection and storage hardware, combined with a growing software layer for establishment management and temperature monitoring, are redefining workflows across donation, processing, storage, and distribution. Stakeholders from blood banks and hospital transfusion services to ambulatory surgical centers and research organizations are recalibrating procurement priorities to emphasize resiliency, automation, and integrated quality controls.

Against this backdrop, procurement decision-makers must balance capital investments in collection devices, pathogen reduction systems, and storage infrastructure with recurring consumable needs such as apheresis kits, tubing, and filters. At the same time, clinical teams are emphasizing component integrity for plasma-derived therapies, transfusion support in oncology and cardiology, and specialized needs for immune and hepatic care. The introductory framing here establishes the operational tensions that follow through the analysis: securing supply continuity, minimizing contamination risk, and enabling seamless traceability through both hardware and software interventions.

An integrated view of transformative technological, operational, and procurement shifts that are redefining safety, automation, and supplier engagement across blood preparation

The landscape of blood preparation is shifting along several convergent vectors that are transforming both supply chains and clinical practice. First, automation is moving beyond single-instrument gains toward orchestrated workflows that integrate automated component extraction, centrifugation, and temperature-aware storage systems, thereby reducing manual handling and variability. Second, safety technologies such as leukoreduction, irradiation, and pathogen inactivation are becoming embedded earlier in processing pathways to reduce downstream risk and support broader clinical use cases. Third, software-enabled process governance is maturing, with temperature monitoring and blood establishment systems providing auditability and compliance support that used to rely on manual recordkeeping.

These shifts are complemented by evolving end-user expectations; hospitals and clinics are increasingly demanding modular systems that can scale with changing case mixes and regulatory requirements. Research and biomanufacturing applications are driving adaptations in processing and storage capabilities to support plasma-derived therapies and novel biologic workflows. Finally, the interplay between disposables and capital equipment is changing procurement models, encouraging suppliers to present lifecycle propositions rather than standalone product sales. Together, these transformative shifts necessitate that clinical, operational, and purchasing leaders rethink supplier relationships, maintenance models, and integration strategies to capture the full value of technological advances.

A clear analysis of how cumulative tariff measures have reshaped procurement dynamics, supplier strategies, and operational resilience across the blood preparation value chain

Recent tariff actions have introduced a material layer of complexity into procurement and supply resilience across the blood preparation value chain. Cumulative tariff measures on imported components, capital equipment, and certain consumables have increased the total cost of ownership for institutions reliant on cross-border suppliers, prompting many organizations to reassess supplier concentration and lead times. As a result, procurement teams are prioritizing dual-sourcing strategies and closer collaboration with regional manufacturers to mitigate exposure to trade policy volatility.

Operationally, tariffs have affected decisions around capital replacement cycles and servicing contracts for items such as apheresis machines, pathogen reduction systems, and temperature-sensitive storage equipment. Institutions that had planned synchronized upgrades are reconsidering schedules to avoid short-term price escalations while continuing to manage compliance and safety imperatives. On the supplier side, manufacturers are responding with localized manufacturing investments, regional distribution hubs, and revised commercial models that emphasize bundled service agreements to offset tariff-driven margins. In parallel, regulatory and customs processing requirements associated with tariff regimes are demanding greater documentation and logistics lead time, which influences blood bank inventory strategies and the timing of elective procedures that depend on reliable transfusion support.

Essential segmentation insights that map offerings, processing methods, clinical applications, automation levels, components, and end-user demands to procurement and innovation priorities

Segmentation drives both product development roadmaps and procurement choices because end users require clarity on how offerings map to clinical and operational needs. Based on offerings, the market encompasses Disposables & Consumables, Equipment, and Software. Disposables & Consumables include items such as apheresis kits, blood bag systems, leukocyte reduction filters, transfer sets, and tubing and needles that determine per-procedure cost and margin for blood centers and hospitals. Equipment comprises collection devices, irradiators, pathogen reduction systems, processing equipment, and storage equipment; collection devices further break down into apheresis machines and blood collection mixers, processing equipment includes automated component extractors and centrifuges, and storage equipment captures blood bank refrigerators, cryogenic freezers, plasma freezers, and platelet incubators and agitators. Software covers blood establishment solutions and temperature monitoring platforms that enable inventory control and regulatory traceability.

Based on component, segmentation differentiates plasma, platelets, red blood cells, and whole blood, each with distinct processing, storage, and clinical utilization profiles. Based on processing automation, offerings span fully automated systems, manual workflows, and semi-automated solutions, which influence staffing models and throughput. Based on preparation method, the range includes apheresis processing, extraction workflows, freezing and cryopreservation, irradiation, leukoreduction, pathogen inactivation, washing and volume adjustment, and whole blood processing, each requiring specific consumables and equipment footprints. Based on application, the market addresses plasma-derived therapies, research and biomanufacturing, and transfusion support; plasma-derived therapies further subdivide into autoimmune and neurologic disorders, liver disease and critical care, and primary immunodeficiency, while transfusion support addresses anemia management, cardiovascular and transplant care, hematological disorders, obstetrics and gynecology, and oncology treatments. Finally, based on end user, demand channels include ambulatory surgical centers, blood banks, clinics, and hospitals, with each end user imposing different scale and compliance requirements that affect product selection and service needs.

A nuanced regional intelligence synthesis describing how Americas, Europe Middle East Africa, and Asia-Pacific dynamics influence adoption, supply resilience, and regulatory compliance

Regional dynamics exert substantial influence on supply chains, regulatory expectations, and adoption timelines for new blood preparation technologies. The Americas context features a mix of large established blood service infrastructures, advanced hospital systems, and an increasing focus on automation and safety technologies. In this environment, procurement decisions are influenced by reimbursement frameworks, established supplier relationships, and the logistical realities of long-distance distribution for temperature-sensitive products.

Europe, the Middle East & Africa presents a heterogeneous tableau where high-regulation markets drive early adoption of compliance-oriented software and pathogen reduction technologies, while emerging markets in the region prioritize scalable, cost-effective disposables and resilient storage solutions. Adoption patterns in this region are mediated by national blood service models and regional trade dynamics. The Asia-Pacific region is characterized by rapid capacity expansion in both hospital services and plasma collection infrastructure, a growing appetite for localized manufacturing to reduce import dependency, and increasing investment in automation and digital quality systems. Across all regions, the interplay between local regulatory frameworks, tariff influences, and healthcare delivery models shapes how quickly new equipment and processes are validated and scaled.

Actionable corporate-level intelligence on how supplier strategies, service models, and partnership approaches are shaping competitive advantage across the blood preparation ecosystem

Competitive dynamics in the blood preparation space are defined less by single-product dominance and more by ecosystem positioning. Leading players differentiate through comprehensive portfolios that combine disposables, capital equipment, and software capabilities, enabling end-to-end value propositions that address procurement preference for fewer vendor interfaces and predictable lifecycle costs. Strategic behaviors observed among major suppliers include forming partnerships with clinical networks to validate new processing technologies, investing in regional service footprints to shorten maintenance lead times, and offering training and accreditation programs that lower implementation friction for sophisticated equipment.

Smaller specialized suppliers are carving sustainable niches by focusing on high-margin consumables, modular add-ons for pathogen reduction, and software modules that integrate with legacy blood establishment systems. Contract manufacturing organizations and regional device assemblers have been expanding capabilities to serve localized demand, particularly where tariff pressures incentivize domestic sourcing. Across the competitive spectrum, successful companies are aligning commercial models to emphasize bundled service agreements, data-enabled support offerings, and interoperability that eases integration with existing blood center workflows.

Practical and prioritized recommendations for suppliers, health systems, and procurement leaders to strengthen resilience, safety, and technology integration in blood preparation

Industry leaders should prioritize a portfolio of strategic actions that directly address supply resilience, safety, and integration. First, adopt a modular procurement strategy that balances capital investment in collection and storage equipment with long-term agreements for disposables and maintenance to stabilize total cost of ownership and reduce exposure to tariff-driven price shocks. Second, accelerate integration of software for blood establishment and temperature monitoring to create transparent, auditable workflows that reduce manual error and support regulatory compliance.

Third, diversify supplier relationships by qualifying regional manufacturers and contract assemblers to shorten lead times and create buffer capacity for critical consumables. Fourth, invest in phased automation that aligns with staffing realities; prioritize semi-automated interventions that deliver immediate reductions in handling risk while planning for fully automated workflows where throughput and budget permit. Fifth, create clinical-laboratory partnerships to validate pathogen reduction and leukoreduction protocols in real-world settings, generating internal evidence that supports broader adoption and payer conversations. Finally, engage proactively with policymakers and customs authorities to streamline import documentation and advocate for tariff treatment that recognizes the clinical imperative of uninterrupted blood supply.

A robust, multi-method research framework combining primary stakeholder interviews, secondary technical and regulatory synthesis, and triangulated thematic validation to underpin strategic insights

The analysis underpinning this executive summary combines a multi-method research approach designed to produce actionable, evidence-based insights. Secondary source synthesis drew on peer-reviewed literature, regulatory guidance, technical standards, and manufacturer technical specifications to build a comprehensive picture of technologies, processes, and compliance requirements. Primary research was conducted through structured interviews with blood bank directors, hospital transfusion leads, procurement professionals, clinical pathologists, and device engineers to surface real-world constraints and adoption drivers.

Data triangulation integrated qualitative interview findings with product feature mappings, supply chain case studies, and regional regulatory reviews to validate themes and identify divergence across regions and end-user types. Segmentation logic was applied iteratively to ensure that offerings, components, processing automation levels, preparation methods, applications, and end users were coherently aligned to observed purchasing behavior and clinical workflows. Where appropriate, scenario analysis was used to stress-test procurement and operational responses to tariff shifts and supply disruptions without attempting to estimate market sizes or forecast quantitative outcomes.

A decisive synthesis of strategic priorities and operational adjustments that unify safety, resilience, and integration as the central imperatives for blood preparation stakeholders

The findings converge on a clear imperative: institutions and suppliers must move from transactional interactions to integrated value partnerships that combine resilient sourcing, automation, and data-enabled quality systems. Providers should view investments in processing automation, pathogen mitigation, and software governance not merely as capital projects but as strategic enablers of clinical consistency and supply resilience. Suppliers who offer modular, service-rich, and interoperable solutions will be best positioned to meet the nuanced demands of diverse end users from ambulatory surgical centers to large hospital networks.

At the same time, procurement teams must adopt a more dynamic risk posture that accounts for tariff volatility and regional manufacturing shifts. By aligning clinical validation programs with procurement cycles and engaging in active supplier qualification, organizations can shorten time-to-adoption for high-value technologies while safeguarding continuity of supply. The conclusions here are intended to guide pragmatic decisions that improve patient safety, operational reliability, and cost transparency across the blood preparation lifecycle.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Emergence of point-of-care blood preparation devices accelerating on-site transfusion readiness in remote clinics
  • 5.2. Shift towards cold chain-free storage solutions leveraging lyophilization technology for room temperature blood products
  • 5.3. Integration of automated blood fractionation systems for faster component separation and reduced contamination risk
  • 5.4. Rising investment in single donor apheresis platforms to optimize yield and minimize donor exposure risk
  • 5.5. Implementation of AI-driven donor screening algorithms to improve match accuracy and reduce transfusion reactions
  • 5.6. Development of universal blood group enzymes to convert A and B antigens and mitigate compatibility challenges
  • 5.7. Accelerating adoption of pathogen reduction for platelets and plasma to standardize safety and extend shelf life
  • 5.8. Adoption of advanced red cell additive and rejuvenation solutions improving post-transfusion viability and enabling longer storage durations
  • 5.9. Deployment of end-to-end digital traceability with RFID and IoT dataloggers to assure chain of custody and temperature compliance
  • 5.10. Growth of contract blood processing and logistics outsourcing as hospitals seek resilient supply amid donor volatility and regional shortages

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Blood Preparation Market, by Offerings

  • 8.1. Introduction
  • 8.2. Disposables & Consumables
    • 8.2.1. Apheresis Kits
    • 8.2.2. Blood Bag Systems
    • 8.2.3. Leukocyte Reduction Filters
    • 8.2.4. Transfer Sets
    • 8.2.5. Tubing & Needles
  • 8.3. Equipment
    • 8.3.1. Collection Devices
      • 8.3.1.1. Apheresis Machines
      • 8.3.1.2. Blood Collection Mixers
    • 8.3.2. Irradiators
    • 8.3.3. Pathogen Reduction Systems
    • 8.3.4. Processing Equipment
      • 8.3.4.1. Automated Component Extractors
      • 8.3.4.2. Centrifuges
    • 8.3.5. Storage Equipment
      • 8.3.5.1. Blood Bank Refrigerators
      • 8.3.5.2. Cryogenic Freezers
      • 8.3.5.3. Plasma Freezers
      • 8.3.5.4. Platelet Incubators & Agitators
  • 8.4. Software
    • 8.4.1. Blood Establishment
    • 8.4.2. Temperature Monitoring

9. Blood Preparation Market, by Component

  • 9.1. Introduction
  • 9.2. Plasma
  • 9.3. Platelets
  • 9.4. Red Blood Cells
  • 9.5. Whole Blood

10. Blood Preparation Market, by Processing Automation

  • 10.1. Introduction
  • 10.2. Fully Automated
  • 10.3. Manual
  • 10.4. Semi-Automated

11. Blood Preparation Market, by Preparation Method

  • 11.1. Introduction
  • 11.2. Apheresis Processing
  • 11.3. Extraction Workflow
  • 11.4. Freezing & Cryopreservation
  • 11.5. Irradiation
  • 11.6. Leukoreduction
  • 11.7. Pathogen Inactivation
  • 11.8. Washing & Volume Adjustment
  • 11.9. Whole Blood Processing

12. Blood Preparation Market, by Application

  • 12.1. Introduction
  • 12.2. Plasma-Derived Therapies
    • 12.2.1. Autoimmune & Neurologic Disorders
    • 12.2.2. Liver Disease & Critical Care
    • 12.2.3. Primary Immunodeficiency
  • 12.3. Research & Biomanufacturing
  • 12.4. Transfusion Support
    • 12.4.1. Anemia Management
    • 12.4.2. Cardiovascular & Transplant
    • 12.4.3. Hematological Disorders
    • 12.4.4. Obstetrics & Gynecology
    • 12.4.5. Oncology Treatments

13. Blood Preparation Market, by End User

  • 13.1. Introduction
  • 13.2. Ambulatory Surgical Centers
  • 13.3. Blood Banks
  • 13.4. Clinics
  • 13.5. Hospitals

14. Americas Blood Preparation Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Blood Preparation Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Blood Preparation Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Fresenius Kabi AG
    • 17.3.2. Terumo Corporation
    • 17.3.3. Grifols, S.A.
    • 17.3.4. GVS S.p.A.
    • 17.3.5. Macopharma S.A.S.
    • 17.3.6. Baxter International Inc.
    • 17.3.7. CSL Limited
    • 17.3.8. B. Braun Melsungen AG
    • 17.3.9. Ortho Clinical Diagnostics Inc.
    • 17.3.10. Abbott Laboratories
    • 17.3.11. AdvaCare Pharma
    • 17.3.12. AstraZeneca PLC
    • 17.3.13. Bayer AG
    • 17.3.14. Becton, Dickinson, and Company
    • 17.3.15. Cardinal Health
    • 17.3.16. Daiichi Sankyo
    • 17.3.17. Exelint International, Co.
    • 17.3.18. GlaxoSmithKline PLC
    • 17.3.19. Greiner Bio-One International GmbH
    • 17.3.20. Medtronic PLC
    • 17.3.21. Pfizer Inc.
    • 17.3.22. QIAGEN N.V
    • 17.3.23. SARSTEDT AG & Co. KG
    • 17.3.24. Shanghai Kohope Medical Devices Co., Ltd.
    • 17.3.25. Immucor, Inc.
    • 17.3.26. Octapharma AG
    • 17.3.27. Kedrion Holding S.p.A.
    • 17.3.28. LFB SA
    • 17.3.29. Sanquin
    • 17.3.30. Medline Industries, Inc.
    • 17.3.31. Mitra Industries Private Limited
    • 17.3.32. Delcon SRL
    • 17.3.33. Labtron Equipment Ltd
    • 17.3.34. Nipro Corporation
    • 17.3.35. Labotronics Scientific LTD.

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

  • FIGURE 1. BLOOD PREPARATION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 20. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. BLOOD PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. BLOOD PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 27. BLOOD PREPARATION MARKET: RESEARCHAI
  • FIGURE 28. BLOOD PREPARATION MARKET: RESEARCHSTATISTICS
  • FIGURE 29. BLOOD PREPARATION MARKET: RESEARCHCONTACTS
  • FIGURE 30. BLOOD PREPARATION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BLOOD PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 159. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 161. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 163. AMERICAS BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 167. AMERICAS BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 169. AMERICAS BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 171. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 211. CANADA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 212. CANADA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 213. CANADA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 214. CANADA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 215. CANADA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 216. CANADA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 217. CANADA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 218. CANADA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 219. CANADA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 220. CANADA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 221. CANADA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. CANADA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 223. CANADA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. CANADA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 225. CANADA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 226. CANADA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 227. CANADA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 228. CANADA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 229. CANADA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. CANADA BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 239. MEXICO BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 240. MEXICO BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 241. MEXICO BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 243. MEXICO BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 245. MEXICO BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 247. MEXICO BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 249. MEXICO BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 251. MEXICO BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. MEXICO BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 255. MEXICO BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 256. MEXICO BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 257. MEXICO BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. MEXICO BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 259. BRAZIL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 261. BRAZIL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 263. BRAZIL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 265. BRAZIL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 267. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 269. BRAZIL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 270. BRAZIL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 271. BRAZIL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 272. BRAZIL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 273. BRAZIL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 274. BRAZIL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 275. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 276. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 277. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 278. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 279. BRAZIL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. BRAZIL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 281. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 282. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 283. BRAZIL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 284. BRAZIL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 285. BRAZIL BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. BRAZIL BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 287. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 288. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 289. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 290. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 291. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 292. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 293. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 294. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 295. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 296. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 297. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 298. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 299. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 300. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 301. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 302. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 303. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 304. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 305. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 306. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 307. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 309. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 310. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 311. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 312. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 313. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST